Background Etanercept, which blocks the action of tumor necrosis factor, reduces disease activity in patients with long-standing rheumatoid arthritis. Its efficacy in reducing disease activity and preventing joint damage in patients with active early rheumatoid arthritis is unknown.Methods We treate...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!